Infliximab for moderate to severe ulcerative colitis: The jury isn't in yet

Kamath, Nagesh and Kamath, Asha and Pai, Ganesh C (2014) Infliximab for moderate to severe ulcerative colitis: The jury isn't in yet. Gastroenterology, 147 (2). pp. 544-545. ISSN 0016-5085

[img] PDF
Journals.pdf - Published Version
Restricted to Registered users only

Download (71kB) | Request a copy

Abstract

The study by Panaccione et al1 concluding that acombination of infliximab (IFX) and azathioprine (AZA) is superior to either drug as monotherapy in moderate to severe ulcerative colitis (UC) made for interesting reading,but also raised a number of questions.

Item Type: Article
Subjects: Medicine > KMC Manipal > Community Medicine
Medicine > KMC Manipal > Gastroenterology
Depositing User: KMC Manipal
Date Deposited: 23 Jul 2014 06:40
Last Modified: 23 Jul 2014 06:40
URI: http://eprints.manipal.edu/id/eprint/140217

Actions (login required)

View Item View Item